Inventor profile of:

Kyle MacBeth

City:

San Francisco, California

Country:

United States

Published Applications:

15

Last publication date:

2023-05-25

Top Assignees for applications by Kyle MacBeth

The entities that hold a legal rights for patent applications filed by inventor MacBeth Kyle:

Recent patent applications by MacBeth Kyle

Kyle MacBeth from San Francisco, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-05-25
US20230158009A1
Human necessities

TREATMENT OF A HEMATOLOGIC MALIGNANCY WITH 2-(4-CHLOROPHENYL)-N-((2-(2,6- DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)METHYL)-2,2-DIFLUOROACETAMIDE

#2 | 2022-12-08
US20220387413A1
Human necessities

ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF

#3 | 2022-01-06
US20220003749A1
Physics

METHODS FOR DETERMINING DRUG EFFICACY FOR THE TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA, MULTIPLE MYELOMA, AND MYELOID CANCERS

#4 | 2021-05-27
US20210154182A1
Human necessities

Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide

#5 | 2020-05-28
US20200163948A1
Human necessities

Antiproliferative compounds and methods of use thereof

#6 | 2019-06-13
US20190175573A1
Human necessities

TREATMENT OF A HEMATOLOGIC MALIGNANCY WITH 2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)METHYL)-2,2-DIFLUOROACETAMIDE

#7 | 2019-01-31
US20190030018A1
Human necessities

COMPOSITIONS AND METHODS OF USE OF 2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)METHYL)-2,2-DIFLUOROACETAMIDE

#8 | 2019-01-03
US20190004033A1
Physics

Methods for determining drug efficacy for the treatment of diffuse large B-cell lymphoma, multiple myeloma, and myeloid cancers

#9 | 2018-10-25
US20180303840A1
Human necessities

Combination therapy for treating malignancies

#10 | 2018-08-09
US20180221361A1
Human necessities

ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF

#11 | 2018-01-25
US20180021325A1
Human necessities

Antiproliferative compounds and methods of use thereof

#12 | 2017-12-07
US20170348298A1
Human necessities

Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide

#13 | 2017-01-12
US20170007590A1
Human necessities

Antiproliferative compounds and methods of use thereof

#14 | 2016-10-27
US20160313300A1
Physics

METHODS FOR DETERMINING DRUG EFFICACY FOR THE TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA, MULTIPLE MYELOMA, AND MYELOID CANCERS

#15 | 2016-01-14
US20160009683A1
Chemistry; metallurgy

Antiproliferative compounds and methods of use thereof

InventorID:

1692595 ⎘